Skip to main content
. 2005 Jun 7;92(12):2122–2128. doi: 10.1038/sj.bjc.6602649

Table 5. Dosing information.

  Irinotecan+5- FU/LV (N=56) Etoposide+5- FU/LV (N=58)
Median number of cycles (range) 2 (0–14) 3 (1–19)
Number of cycles administered as planned 33 (59%) 48 (82%)
Median months of treatment duration (range) 3.6 (0–22) 1.5 (0–15)
Number (%) of administration delays 39 (70) 30 (52)
Number (%) of dose reductions 42 (75) 26 (45)

5-FU=5-fluorouracil; LV=leucovorin.